Market Closed -
Nyse
04:00:02 2024-05-24 pm EDT
|
5-day change
|
1st Jan Change
|
349.3
USD
|
-0.83%
|
|
-1.94%
|
-23.70%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
48,537
|
54,296
|
59,622
|
64,843
|
56,361
|
42,443
|
-
|
-
|
Enterprise Value (EV)
1 |
50,149
|
56,283
|
68,722
|
70,908
|
63,323
|
47,765
|
47,198
|
46,610
|
P/E ratio
|
18.2
x
|
16.2
x
|
20.5
x
|
23.2
x
|
22.9
x
|
23.3
x
|
17.9
x
|
14.2
x
|
Yield
|
0.6%
|
0.61%
|
0.59%
|
0.62%
|
-
|
1.06%
|
1.14%
|
1.21%
|
Capitalization / Revenue
|
0.75
x
|
0.7
x
|
0.72
x
|
0.7
x
|
0.53
x
|
0.37
x
|
0.37
x
|
0.35
x
|
EV / Revenue
|
0.77
x
|
0.73
x
|
0.83
x
|
0.76
x
|
0.6
x
|
0.42
x
|
0.41
x
|
0.38
x
|
EV / EBITDA
|
13.6
x
|
13.3
x
|
21.5
x
|
13.8
x
|
11.1
x
|
12.1
x
|
10.2
x
|
8.76
x
|
EV / FCF
|
11
x
|
12
x
|
72.6
x
|
20.5
x
|
21.3
x
|
24.8
x
|
15
x
|
12.7
x
|
FCF Yield
|
9.07%
|
8.31%
|
1.38%
|
4.89%
|
4.7%
|
4.03%
|
6.65%
|
7.85%
|
Price to Book
|
4.02
x
|
3.85
x
|
3.73
x
|
4.18
x
|
3.44
x
|
2.68
x
|
2.49
x
|
2.26
x
|
Nbr of stocks (in thousands)
|
132,426
|
132,341
|
128,534
|
126,600
|
123,111
|
120,501
|
-
|
-
|
Reference price
2 |
366.5
|
410.3
|
463.9
|
512.2
|
457.8
|
352.2
|
352.2
|
352.2
|
Announcement Date
|
2/5/20
|
2/3/21
|
2/2/22
|
2/1/23
|
1/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
64,888
|
77,155
|
83,064
|
92,870
|
106,374
|
113,886
|
115,709
|
121,710
|
EBITDA
1 |
3,697
|
4,240
|
3,201
|
5,122
|
5,711
|
3,945
|
4,636
|
5,319
|
EBIT
1 |
3,262
|
3,751
|
2,488
|
4,413
|
4,999
|
3,174
|
3,819
|
4,538
|
Operating Margin
|
5.03%
|
4.86%
|
3%
|
4.75%
|
4.7%
|
2.79%
|
3.3%
|
3.73%
|
Earnings before Tax (EBT)
1 |
3,456
|
4,600
|
3,354
|
3,568
|
3,383
|
2,380
|
3,120
|
3,732
|
Net income
1 |
2,707
|
3,367
|
2,933
|
2,806
|
2,489
|
1,799
|
2,329
|
2,823
|
Net margin
|
4.17%
|
4.36%
|
3.53%
|
3.02%
|
2.34%
|
1.58%
|
2.01%
|
2.32%
|
EPS
2 |
20.10
|
25.31
|
22.67
|
22.08
|
20.00
|
15.10
|
19.70
|
24.73
|
Free Cash Flow
1 |
4,548
|
4,675
|
946
|
3,467
|
2,977
|
1,927
|
3,139
|
3,660
|
FCF margin
|
7.01%
|
6.06%
|
1.14%
|
3.73%
|
2.8%
|
1.69%
|
2.71%
|
3.01%
|
FCF Conversion (EBITDA)
|
123.02%
|
110.26%
|
29.55%
|
67.69%
|
52.13%
|
48.85%
|
67.72%
|
68.8%
|
FCF Conversion (Net income)
|
168.01%
|
138.85%
|
32.25%
|
123.56%
|
119.61%
|
107.12%
|
134.78%
|
129.63%
|
Dividend per Share
2 |
2.200
|
2.500
|
2.725
|
3.150
|
-
|
3.745
|
4.006
|
4.263
|
Announcement Date
|
2/5/20
|
2/3/21
|
2/2/22
|
2/1/23
|
1/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
21,054
|
23,970
|
23,662
|
22,799
|
22,439
|
26,742
|
26,747
|
26,423
|
26,462
|
29,611
|
28,352
|
27,919
|
27,913
|
30,171
|
29,033
|
EBITDA
1 |
434
|
1,604
|
1,501
|
1,200
|
640
|
1,875
|
1,854
|
1,459
|
508
|
1,639
|
1,237
|
983.9
|
272.4
|
1,458
|
1,398
|
EBIT
1 |
240
|
1,415
|
1,313
|
1,018
|
458
|
1,657
|
1,530
|
1,258
|
322
|
1,397
|
1,065
|
793.5
|
66.8
|
1,308
|
1,214
|
Operating Margin
|
1.14%
|
5.9%
|
5.55%
|
4.47%
|
2.04%
|
6.2%
|
5.72%
|
4.76%
|
1.22%
|
4.72%
|
3.76%
|
2.84%
|
0.24%
|
4.33%
|
4.18%
|
Earnings before Tax (EBT)
1 |
-60
|
1,220
|
1,122
|
1,297
|
-71
|
1,614
|
1,262
|
1,098
|
-591
|
1,014
|
864.8
|
679.8
|
-152.7
|
1,245
|
1,123
|
Net income
1 |
-14
|
930
|
696
|
1,195
|
-15
|
1,239
|
959
|
832
|
-541
|
741
|
688.7
|
475.9
|
-137.5
|
896.3
|
796.2
|
Net margin
|
-0.07%
|
3.88%
|
2.94%
|
5.24%
|
-0.07%
|
4.63%
|
3.59%
|
3.15%
|
-2.04%
|
2.5%
|
2.43%
|
1.7%
|
-0.49%
|
2.97%
|
2.74%
|
EPS
2 |
-0.1100
|
7.290
|
5.480
|
9.390
|
-0.1200
|
9.870
|
7.660
|
6.710
|
-4.420
|
6.110
|
5.693
|
3.950
|
-1.140
|
7.474
|
6.653
|
Dividend per Share
2 |
0.7000
|
0.7875
|
0.7875
|
0.7875
|
0.7875
|
0.8850
|
0.8850
|
-
|
-
|
0.8850
|
0.9800
|
0.9800
|
0.9800
|
1.007
|
1.023
|
Announcement Date
|
2/2/22
|
4/27/22
|
7/27/22
|
11/2/22
|
2/1/23
|
4/26/23
|
8/2/23
|
11/1/23
|
1/25/24
|
4/24/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,612
|
1,987
|
9,100
|
6,065
|
6,962
|
5,322
|
4,755
|
4,167
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.436
x
|
0.4686
x
|
2.843
x
|
1.184
x
|
1.219
x
|
1.349
x
|
1.026
x
|
0.7834
x
|
Free Cash Flow
1 |
4,548
|
4,675
|
946
|
3,467
|
2,977
|
1,927
|
3,139
|
3,660
|
ROE (net income / shareholders' equity)
|
21.7%
|
19.4%
|
17.9%
|
20.4%
|
20.6%
|
12.5%
|
14.9%
|
17.1%
|
ROA (Net income/ Total Assets)
|
8.84%
|
12.8%
|
7.39%
|
6.42%
|
7.21%
|
3.9%
|
4.83%
|
5.57%
|
Assets
1 |
30,633
|
26,224
|
39,664
|
43,706
|
34,544
|
46,087
|
48,229
|
50,716
|
Book Value Per Share
2 |
91.10
|
107.0
|
124.0
|
123.0
|
133.0
|
131.0
|
142.0
|
156.0
|
Cash Flow per Share
2 |
39.20
|
42.40
|
17.50
|
36.10
|
32.00
|
21.70
|
32.00
|
41.00
|
Capex
1 |
736
|
964
|
1,316
|
1,120
|
1,004
|
809
|
900
|
980
|
Capex / Sales
|
1.13%
|
1.25%
|
1.58%
|
1.21%
|
0.94%
|
0.71%
|
0.78%
|
0.8%
|
Announcement Date
|
2/5/20
|
2/3/21
|
2/2/22
|
2/1/23
|
1/25/24
|
-
|
-
|
-
|
Last Close Price
352.2
USD Average target price
367.9
USD Spread / Average Target +4.45% Consensus |
1st Jan change
|
Capi.
|
---|
| -23.71% | 42.44B | | -2.97% | 476B | | +10.78% | 95.97B | | +1.66% | 41.27B | | -6.58% | 19.98B | | -27.37% | 2.59B | | -16.72% | 1.35B | | +3.99% | 490M |
Other Managed Healthcare
|